Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.21% vs -11.94% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 36.59% vs -38.19% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -64.51% vs -30.04% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -50.00% vs 300.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of China Resources Boya Bio-pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.21% vs -11.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.43% vs -46.20% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 36.59% vs -38.19% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 21.61% vs -31.66% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -64.51% vs -30.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -66.26% vs -22.78% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -50.00% vs 300.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






